Pfizer recently filed at least seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication, Nurtec, which is used to prevent and treat migraines.
These suits were surfaced by Law.com Radar, ALM’s source for immediate alerting on just filed cases in state and federal courts. Pfizer’s aggressive legal move highlights the ongoing battles within the pharmaceutical industry over patent rights and the marketing of generic drugs.
For further details, visit the Delaware Law Weekly’s full article.